City of Hope Names Renowned Researcher Michael Caligiuri President and Physician-in-Chief

January 5, 2018 | City of Hope

Michael A. Caligiuri, M.D., a world-renowned cancer researcher, has been named president of City of Hope National Medical Center and physician-in-chief of City of Hope.

Continue Reading

Building Better Antibodies with John Williams, Ph.D.

April 19, 2018 | City of Hope

Researchers at Beckman Research Institute of City of Hope use novel technology to add new functionalities to already potent proteins.

New Scientist dedicates much of his research program to acute myeloid leukemia

February 27, 2018 | City of Hope

Jianjun Chen, Ph.D.'s, long-term goal is to further advance the understanding of cancer biology, and AML in particular, and to translate the discoveries from basic research into clinical application.

City of Hope Researcher Seeks New Cure for Hemophilia

February 21, 2018 | Katie Neith

Saswati Chatterjee, Ph.D., a professor in the Department of Surgery and member of the Beckman Research Institute at City of Hope, thinks she may know a way to cure hemophilia A.

City of Hope's CEACAM Research Comes Full Circle with New CAR T Approach

February 9, 2018 | Jyoti Madhusoodanan

More than 50 years after its discovery, CEA remains one of the most widely used clinical markers of cancer. As the diverse roles of CEA and its family members, known as CEA-related cell adhesion molecules (CEACAMs), have grown clearer, researchers at City of Hope are working on a new wave of clinical tools and therapies.

Core Connection: Analytical Pharmacology

February 2, 2018 | Katie Neith

City of Hope has established a robust drug discovery and development pipeline that provides researchers with all the expertise they need to bring their ideas to reality.

New Hire: Farah R. Abdulla, M.D.

January 25, 2018 | City of Hope

Farah Abdulla, M.D., specializes in the research and treatment of cutaneous lymphoma, a rare form of non-Hodgkin lymphoma that affects the skin.

New Hire: Daniel Jae Kim

January 25, 2018 | City of Hope

Daniel Jae Kim, M.D., is based at City of Hope's South Pasadena facility and specializes in hematology and oncology.

TGen Brings Greater Precision to CAR T Therapies

January 25, 2018 | City of Hope

As an affiliate of City of Hope, TGen will use its genomics expertise to chart a path to greater precision in CAR T therapies for cancer patients.

Load More